Par Drugs And Chemicals Limited (NSE: PAR) is a Vadodara, Gujarat-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹135 Cr, it ranks #3,008 by market cap among the 6,137 Indian listed companies on FinBizNet, and #65 of 86 in Medicinal Chemicals and Botanical Products. At ₹103.43 (as of 25 Oct 2026), the share price is 42.5% below its 52-week high of ₹180.00 and 32.5% above its 52-week low of ₹78.05. The share price is up 1.2% over one year and up 10.3% over three months.
| Current Price | ₹103.43 |
|---|---|
| Market Cap | ₹135 Cr |
| NSE Symbol | PAR |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products |
| P/E Ratio | 9.9 |
| Return on Equity | 12.43% |
| Return on Assets | 6.75% |
| 52-Week Range | ₹78.05 – ₹180.00 |
| 1-Year Price Change | +1.2% |
| 3-Month Price Change | +10.3% |
| Beta (1Y) | 0.51 |
| Dividend Yield | 0.00% |
| Headquarters | Vadodara, Gujarat |
| Website | www.pardrugs.com |
| Revenue | ₹31 Cr |
|---|---|
| Net Profit | ₹5 Cr |
| Net Margin | 15.1% |
| EPS (Basic) | ₹3.83 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, Alusil, PARSIL-HT, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.
1. Manufacturing of API-This segment manufactures and sells active pharmaceutical ingredients.
1. Manufacturing of API-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4,21,995 Cr | 36.4 | 14.72% | ₹15,300 Cr | +5.4% |
| Zydus Lifesciences Ltd | ₹1,12,020 Cr | 22.2 | 18.32% | ₹8,017 Cr | +14.7% |
| Laurus Labs Ltd | ₹1,11,310 Cr | 125.3 | 17.74% | ₹2,026 Cr | +125.7% |
| Cipla Limited | ₹1,07,048 Cr | 27.6 | 11.74% | ₹7,119 Cr | -14.7% |
| Dr.Reddys Lab | ₹1,02,611 Cr | 24.1 | 11.52% | ₹8,698 Cr | -0.9% |
| Aurobindo Pharma Ltd. | ₹95,910 Cr | 26.8 | 9.93% | ₹9,150 Cr | +41.7% |
| Mankind Pharma | ₹93,977 Cr | 48.7 | 12.45% | ₹4,031 Cr | -9.9% |
| Lupin Ltd | ₹89,426 Cr | 16.6 | 26.91% | ₹8,277 Cr | -1.1% |
| Par Drugs And Chemicals Limited | ₹135 Cr | 9.9 | 12.43% | ₹31 Cr | +1.2% |
Listed by market capitalisation. Ratios are shown for context only.
Par Drugs And Chemicals Limited is trading at ₹103.43, with a market capitalisation of ₹135 Cr.
Par Drugs And Chemicals Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).
Par Drugs And Chemicals Limited has a P/E of 9.9 and a return on equity of 12.43%.
Par Drugs And Chemicals Limited is listed on the NSE under the symbol PAR.
Par Drugs And Chemicals Limited's share price is up 1.2% over one year and up 10.3% over three months. Its 52-week range is ₹78.05 to ₹180.00.
In Q1 FY27, Par Drugs And Chemicals Limited reported revenue of ₹31 Cr and net profit of ₹5 Cr, with basic EPS of ₹3.83 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.